Fingolimod cuts the frequency of MS relapses by about 50%. It is more effective than interferon beta-la for reducing relapse frequency and slowing brain inflammation and damage that can be seen on an MRI. Some studies show that it can slow disability, but a newer study does not confirm this.
This answer was adapted from Sharecare's award-winning AskMD app. Start a consultation now to find out what's causing your symptoms, learn how to manage a condition, or find a doctor.
Continue Learning about Multiple Sclerosis Treatment
Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.